Randomised Placebo-controlled Study of Grass Pollen Allergen Immunotherapy Tablet (AIT) for Seasonal Rhinitis: Time Course of Nasal, Cutaneous and Immunological Outcomes
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Mar 2019
Price : $35 *
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Grass pollen hypersensitivity
- Focus Therapeutic Use
- 25 Mar 2019 The trial has been completed in UK-MHRA (End Date; 2017-03-01).
- 28 Sep 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Apr 2015, according to ClinicalTrials.gov record.
- 07 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.